Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case

Surgery Today

Volumn 41, Issue 9, 2011, Pages 1290-1293

  Ando, Koji ^a   Oki, Eiji ^a   Sugiyama, Masahiko ^a   Zhao, Yan ^a   Kojima, Aya ^b   Yamamoto, Hidetaka ^b   Yamashita, Yoichi ^a   Saeki, Hiroshi ^a   Taketomi, Akinobu ^a   Morita, Masaru ^a   Kakeji, Yoshihiro ^a   Tsujitani, Shunichi ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Extra gastrointestinal stromal tumor; Imatinib mesylate; KIT gene mutation; Secondary resistance

Indexed keywords

CD34 ANTIGEN; DNA; EOSIN; HEMATOXYLIN; IMATINIB; STEM CELL FACTOR; SUNITINIB;

ABDOMINAL DISTENSION; ADULT; ARTICLE; CANCER RESISTANCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DNA EXTRACTION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG SAFETY; EXON; EYE EDEMA; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; KIT GENE; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; NEEDLE BIOPSY; OUTCOME ASSESSMENT; TISSUE NECROSIS; TREATMENT DURATION; TREATMENT RESPONSE;

ABDOMINAL NEOPLASMS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, CONNECTIVE TISSUE; NEOPLASMS, MULTIPLE PRIMARY; PIPERAZINES; PYRIMIDINES;

EID: 80052416180     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4477-8     Document Type: Article

References (24)

1. L.G. Kindblom H.E. Remotti F. Aldenborg J.M. Meis-Kindblom 1998 Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal Am J Pathol 152 1259 1269 9588894 1:STN:280:DyaK1c3kvVejug%3D%3D
2. T.L. Robinson K. Sircar B.R. Hewlett K. Chorneyko R.H. Riddell J.D. Huizinga 2000 Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal Am J Pathol 156 1157 1163 10751339 10.1016/S0002-9440(10)64984-X 1:CAS:528:DC%2BD3cXjtV2isLY%3D
3. M. Miettinen J. Lasota 2006 Gastrointestinal stromal tumors: pathology and prognosis at different sites Semin Diagn Pathol 23 70 83 17193820 10.1053/j.semdp.2006.09.001
4. J. Lasota M. Miettinen 2006 KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs) Semin Diagn Pathol 23 91 102 17193822 10.1053/j.semdp.2006.08.006
5. J. Andersson P. Bumming J.M. Meis-Kindblom H. Sihto N. Nupponen H. Joensuu, et al. 2006 Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis Gastroenterology 130 1573 1581 16697720 10.1053/j.gastro.2006.01.043 1:CAS:528:DC%2BD28Xls1Wisbg%3D
6. H. Yamamoto Y. Oda K. Kawaguchi N. Nakamura T. Takahira S. Tamiya, et al. 2004 c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue) Am J Surg Pathol 28 479 488 15087667 10.1097/00000478-200404000-00007
7. Y.Y. Hou Y.S. Tan M.H. Sun Y.K. Wei J.F. Xu S.H. Lu, et al. 2004 C-kit gene mutation in human gastrointestinal stromal tumors World J Gastroenterol 10 1310 1314 15112348 1:CAS:528:DC%2BD2cXnsVCnsb4%3D
8. J. Lasota A. Dansonka-Mieszkowska T. Stachura R. Schneider-Stock M. Kallajoki S.E. Steigen, et al. 2003 Gastrointestinal stromal tumors with internal tandem duplications in 3′ end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course Mod Pathol 16 1257 1264 14681327 10.1097/01.MP.0000097365.72526.3E
9. S. Sakurai T. Hishima Y. Takazawa T. Sano T. Nakajima K. Saito, et al. 2001 Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum Pathol Int 51 524 531 11472565 10.1046/j.1440-1827.2001.01224.x 1:STN:280:DC%2BD3MvosVKrsA%3D%3D
10. J. Lasota M. Miettinen 2008 Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours Histopathology 53 245 266 18312355 10.1111/j.1365-2559.2008.02977.x 1:STN:280:DC%2BD1cnmslyjsQ%3D%3D
11. M. Castillo-Sang S. Mancho A.W. Tsang B. Gociman B. Almaroof M.Y. Ahmed 2008 A malignant omental extra-gastrointestinal stromal tumor on a young man: a case report and review of the literature World J Surg Oncol 6 50 18479530 10.1186/1477-7819-6-50
12. M. Miettinen L.H. Sobin J. Lasota 2009 Gastrointestinal stromal tumors presenting as omental masses-a clinicopathologic analysis of 95 cases Am J Surg Pathol 33 1267 1275 19440146 10.1097/PAS.0b013e3181a13e99
13. T. Terada 2009 Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations Med Oncol 26 233 237 18777214 10.1007/s12032-008-9092-9
14. T. Todoroki T. Sano S. Sakurai A. Segawa T. Saitoh K. Fujikawa, et al. 2007 Primary omental gastrointestinal stromal tumor (GIST) World J Surg Oncol 5 66 17565683 10.1186/1477-7819-5-66
15. G.D. Demetri 2002 Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571) Eur J Cancer 38suppl5 S52 S59 10.1016/S0959-8049(02)80603-7
16. H. Joensuu P.J. Roberts M. Sarlomo-Rikala L.C. Andersson P. Tervahartiala D. Tuveson, et al. 2001 Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 1052 1056 11287975 10.1056/NEJM200104053441404 1:STN:280:DC%2BD3M3gvVekuw%3D%3D
17. M. Debiec-Rychter R. Sciot A. Le Cesne M. Schlemmer P. Hohenberger A.T. van Oosterom, et al. 2006 KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours Eur J Cancer 42 1093 1103 16624552 10.1016/j.ejca.2006.01.030 1:CAS:528:DC%2BD28Xks1ertb0%3D
18. T. Akiyoshi M. Oya Y. Fujimoto H. Kuroyanagi M. Ueno T. Yamaguchi, et al. 2010 Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case Surg Today 40 272 276 20180084 10.1007/s00595-008-4037-7
19. M.C. Heinrich C.L. Corless C.D. Blanke G.D. Demetri H. Joensuu P.J. Roberts, et al. 2006 Molecular correlates of imatinib resistance in gastrointestinal stromal tumors J Clin Oncol 24 4764 4774 16954519 10.1200/JCO.2006.06.2265 1:CAS:528:DC%2BD28XhtFynsrrN
20. E. Wardelmann S. Merkelbach-Bruse K. Pauls N. Thomas H.U. Schildhaus T. Heinicke, et al. 2006 Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate Clin Cancer Res 12 1743 1749 16551858 10.1158/1078-0432.CCR-05-1211 1:CAS:528:DC%2BD28Xis1Cjs7Y%3D
21. J. Verweij P.G. Casali J. Zalcberg A. LeCesne P. Reichardt J.Y. Blay, et al. 2004 Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial Lancet 364 1127 1134 15451219 10.1016/S0140-6736(04)17098-0 1:CAS:528:DC%2BD2cXnvVOiu7o%3D
22. T. Nishida T. Kanda A. Nishitani T. Takahashi K. Nakajima T. Ishikawa, et al. 2008 Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor Cancer Sci 99 799 804 18294292 10.1111/j.1349-7006.2008.00727.x 1:CAS:528:DC%2BD1cXlsFyls7w%3D
23. B. Liegl I. Kepten C. Le M. Zhu G.D. Demetri M.C. Heinrich, et al. 2008 Heterogeneity of kinase inhibitor resistance mechanisms in GIST J Pathol 216 64 74 18623623 10.1002/path.2382 1:CAS:528:DC%2BD1cXhtFSrtbbF
24. M.C. Heinrich C.L. Corless G.D. Demetri C.D. Blanke M. von Mehren H. Joensuu, et al. 2003 Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor J Clin Oncol 21 4342 4349 14645423 10.1200/JCO.2003.04.190 1:CAS:528:DC%2BD2cXpsVWqu7Y%3D